COVID



dynaCERT Inc.
Latest Comments
image_pdfimage_print

Fully funded with strong IP Portfolio, Hemostemix marches forward towards FDA Phase II Clinical Trial Completion

Hemostemix Inc. (TSXV: HEM | OTC: HMTXF) continues to move forward with its FDA Phase II clinical trial program of […]


Sixth Wave Hits Key Achievement for a New & Innovative Rapid Detection System for COVID-19

Yesterday, Sixth Wave Innovations Inc. (CSE: SIXW | OTCQB: ATURF | FSE: AHUH ) announced a key achievement in the […]


With Cancer-Testing Telehealth Platform on Track for Q1 Launch, StageZero Shareholders Await Covid-19 Testing-Related Revenue Results

StageZero Life Sciences Ltd. (TSX: SZLS | OTC: GNWSF | FSE: 61N) is a life science and telehealth company that […]


Revenue Forecasted to Triple as Valeo Benefits from Last Year’s Successes

Valeo Pharma Inc. (CSE: VPH | OTC: VPHIF |FSE: VP2) is a specialty pharmaceutical company and its revenue is expected […]


Predictiv AI debuts real-world problem solver, a fever detection system called ThermalPass

“If you can predict the future, you can profit from it…” All you good capitalists out there should be salivating […]


ZEN Graphene Solutions moves towards commercialization of virus-killing mask

ZEN is collaborating with partners to develop virucidal face masks and PPE Back in May 2020 InvestorIntel wrote about the […]


James Howard-Tripp on applying StageZero’s cancer diagnostics expertise to COVID-19 testing

InvestorIntel’s Tracy Weslosky talks with James Howard-Tripp, Chairman and CEO of StageZero Life Sciences Ltd. (TSX: SZLS), about StageZero’s early […]